Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresis Front Immunol
Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial Lancet
Corrigendum to "Effects of Mediterranean diet or Mindfulness-Based Stress Reduction during pregnancy on maternal gut and vaginal microbiota: a subanalysis of the Improving Mothers for a better PrenAtal Care Trial BarCeloNa (IMPACT BCN) trial." [Am J Clin Nutr. 2025 Oct;122(4):1121-1133. doi: 10.1016/j.ajcnut.2025.07.030. Epub 2025 Aug 5. PMID: 40759394; PMCID: PMC12674037.] Am J Clin Nutr
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption Cancer Res
A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 study Future Oncol
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study CANCER-AM CANCER SOC